Fang Xu

1.3k total citations
54 papers, 937 citations indexed

About

Fang Xu is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Fang Xu has authored 54 papers receiving a total of 937 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Pharmacology. Recurrent topics in Fang Xu's work include Pharmacological Effects of Natural Compounds (8 papers), Immunotherapy and Immune Responses (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Fang Xu is often cited by papers focused on Pharmacological Effects of Natural Compounds (8 papers), Immunotherapy and Immune Responses (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Fang Xu collaborates with scholars based in China, United States and South Africa. Fang Xu's co-authors include Huaxing Dai, Jialu Xu, Yue Zhang, Qingle Ma, Chao Wang, Qianyu Yang, Beilei Wang, Yitong Chen, Ying Cheng and Qin Fan and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Fang Xu

52 papers receiving 930 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fang Xu China 18 403 213 146 104 103 54 937
Han‐Jin Park South Korea 19 359 0.9× 211 1.0× 45 0.3× 76 0.7× 73 0.7× 72 937
Yinhua Zhu China 12 346 0.9× 105 0.5× 83 0.6× 87 0.8× 65 0.6× 42 734
Sabine U. Vorrink Sweden 15 425 1.1× 261 1.2× 119 0.8× 150 1.4× 169 1.6× 18 1.2k
Marzanna Cechowska‐Pasko Poland 19 438 1.1× 120 0.6× 74 0.5× 131 1.3× 138 1.3× 57 989
So‐Hyun Park South Korea 19 419 1.0× 56 0.3× 234 1.6× 69 0.7× 169 1.6× 48 1.1k
Ching-Hao Li Taiwan 20 469 1.2× 89 0.4× 90 0.6× 143 1.4× 132 1.3× 36 1.1k
Katsumi Fukamachi Japan 20 390 1.0× 119 0.6× 85 0.6× 195 1.9× 241 2.3× 61 1.2k

Countries citing papers authored by Fang Xu

Since Specialization
Citations

This map shows the geographic impact of Fang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fang Xu more than expected).

Fields of papers citing papers by Fang Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fang Xu. The network helps show where Fang Xu may publish in the future.

Co-authorship network of co-authors of Fang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Fang Xu. A scholar is included among the top collaborators of Fang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fang Xu. Fang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Fang, et al.. (2025). 1-Epilupinine enhances cognition and reduces inflammation in scopolamine-induced dementia model mice. Neuroscience Letters. 852. 138184–138184. 1 indexed citations
2.
Ma, Qingle, Heng Wang, Bingbing Wu, et al.. (2025). Targeting myeloid cells with platelet-derived extracellular vesicles to overcome resistance of immune checkpoint blockade therapy. Biomaterials. 321. 123336–123336. 3 indexed citations
3.
Xu, Jialu, Yue Zhang, Huaxing Dai, et al.. (2024). Oral administration of garlic-derived nanoparticles improves cancer immunotherapy by inducing intestinal IFNγ-producing γδ T cells. Nature Nanotechnology. 19(10). 1569–1578. 32 indexed citations
4.
Zhao, Jingjing, Ta‐Hsiang Chao, Min Zhou, et al.. (2024). Decellularization techniques pave the way for tissue engineering and regenerative medicine: a narrative review. 1(2). 117–130. 3 indexed citations
5.
Xia, Yang, Hongwei� Jiang, Jinwen Chen, et al.. (2023). Low dose Taxol ameliorated renal fibrosis in mice with diabetic kidney disease by downregulation of HIPK2. Life Sciences. 320. 121540–121540. 2 indexed citations
6.
Xu, Fang, Jialu Xu, Huaxing Dai, et al.. (2023). Engineering of dendritic cell bispecific extracellular vesicles for tumor-targeting immunotherapy. Cell Reports. 42(10). 113138–113138. 20 indexed citations
7.
Yang, Qianyu, Huaxing Dai, Ying Cheng, et al.. (2023). Oral feeding of nanoplastics affects brain function of mice by inducing macrophage IL-1 signal in the intestine. Cell Reports. 42(4). 112346–112346. 81 indexed citations
8.
Wang, Mengmeng, Man Yang, Yawen Zhang, et al.. (2022). Synergistic antitumor activity of 5-fluorouracil and atosiban against microsatellite stable colorectal cancer through restoring GATA3. Biochemical Pharmacology. 199. 115025–115025. 3 indexed citations
9.
Dai, Huaxing, Qianyu Yang, Rong Sun, et al.. (2022). Nanoparticle accumulation in liver may induce resistance to immune checkpoint blockade therapy. Nano Research. 16(4). 5237–5246. 5 indexed citations
10.
Olaleye, Olajide E., Wei Yang, Feifei Du, et al.. (2021). Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsule. Acta Pharmacologica Sinica. 42(12). 2155–2172. 27 indexed citations
11.
Zhang, Haiyan, Wei Niu, Olajide E. Olaleye, et al.. (2020). Comparison of intramuscular and intravenous pharmacokinetics of ginsenosides in humans after dosing XueShuanTong, a lyophilized extract of Panax notoginseng roots. Journal of Ethnopharmacology. 253. 112658–112658. 17 indexed citations
12.
Zuo, Di, Feng Wang, Weifang Rong, et al.. (2020). The novel estrogen receptor GPER1 decreases epilepsy severity and susceptivity in the hippocampus after status epilepticus. Neuroscience Letters. 728. 134978–134978. 15 indexed citations
13.
Shen, Jian, et al.. (2019). Quality of life in caregivers of young children with Prader–Willi syndrome. World Journal of Pediatrics. 15(5). 506–510. 18 indexed citations
14.
15.
Dong, Jiajia, Olajide E. Olaleye, Rongrong Jiang, et al.. (2018). Glycyrrhizin has a high likelihood to be a victim of drug–drug interactions mediated by hepatic organic anion‐transporting polypeptide 1B1/1B3. British Journal of Pharmacology. 175(17). 3486–3503. 21 indexed citations
16.
Zhao, Xiaopeng, Lu Ma, Fei Chang, et al.. (2017). Improvement of pregnancy outcome by extending embryo culture in IVF-ET during clinical application. Journal of Assisted Reproduction and Genetics. 35(2). 321–329. 10 indexed citations
17.
Xu, Fang, et al.. (2016). Quantitative determination of AI-2 quorum-sensing signal of bacteria using high performance liquid chromatography–tandem mass spectrometry. Journal of Environmental Sciences. 52. 204–209. 21 indexed citations
18.
Wang, Li, Yan Sun, Feifei Du, et al.. (2007). ‘LC‐electrolyte effects’ improve the bioanalytical performance of liquid chromatography/tandem mass spectrometric assays in supporting pharmacokinetic study for drug discovery. Rapid Communications in Mass Spectrometry. 21(16). 2573–2584. 23 indexed citations
19.
Huang, Yi, Qian Zhou, Ming Yan, et al.. (2005). [Study of the content of flavonoids of different parts in Saussures involucrata and their HPLC fingerprint chromatogram].. PubMed. 28(11). 980–2. 4 indexed citations
20.
Li, Chuan, Fajun Nan, Ping Liu, et al.. (2002). Liquid chromatography/tandem mass spectrometry for the determination of fluoxetine and its main active metabolite norfluoxetine in human plasma with deuterated fluoxetine as internal standard. Rapid Communications in Mass Spectrometry. 16(19). 1844–1850. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Han‐Jin Park Breakdown of academic impact, for papers by Yinhua Zhu Breakdown of academic impact, for papers by Sabine U. Vorrink Breakdown of academic impact, for papers by Marzanna Cechowska‐Pasko Breakdown of academic impact, for papers by So‐Hyun Park Breakdown of academic impact, for papers by Ching-Hao Li Breakdown of academic impact, for papers by Katsumi Fukamachi
Rankless by CCL
2026